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dUTPases catalyze the hydrolysis of dUTP into dUMP and
pyrophosphate tomaintain the proper nucleotide pool for DNA
metabolism. Recent evidence suggests that dUTPases may also
represent a selective drug target in mycobacteria because of the
crucial role of these enzymes in maintaining DNA integrity.
Nucleotide-hydrolyzing enzymes typically harbor a buried
ligand-binding pocket at interdomain or intersubunit clefts,
facilitating proper solvent shielding for the catalyzed reaction.
The mechanism by which substrate binds this hidden pocket
and product is released in dUTPases is unresolved because of
conflicting crystallographic and spectroscopic data. We sought
to resolve this conflict by using a combination of random accel-
eration molecular dynamics (RAMD) methodology and struc-
tural and biochemical methods to study the dUTPase from
Mycobacterium tuberculosis. In particular, theRAMDapproach
used in this study provided invaluable insights into the nucleo-
tide dissociation process that reconciles all previous experimen-
tal observations. Specifically, our data suggest that nucleotide
binding takes place as a small stretch of amino acids transiently
slides away and partially uncovers the active site. The in silico
data further revealed a newdUTPase conformation on the path-
way to a relatively open active site. To probe this model, we
developed the Trp21 reporter and collected crystallographic,
spectroscopic, and kinetic data that confirmed the interaction
of Trp21 with the active site shielding C-terminal arm, suggest-
ing that the RAMD method is effective. In summary, our com-
putational simulations and spectroscopic results support the
idea that small loopmovements in dUTPase allow the shuttling
of the nucleotides between the binding pocket and the solvent.
Commonly, nucleotide-hydrolyzing enzymes harbor a bind-
ing pocket for their cognate ligand at interdomain or intersub-
unit clefts. This arrangement facilitates proper solvent shield-
ing for the catalyzed reaction. Many well described enzymes
bind nucleotides in a relatively open (e.g. DNA and RNA heli-
cases, molecular motors, and small G-proteins) or completely
open (ATP-dependent DNA ligases) binding pocket. Confor-
mational changes associated with nucleotide binding result in
the closure of the active site, enabling the subsequent reaction
steps (1–5). The conformational change of the enzyme upon
nucleotide binding can be understood by comparing the avail-
able apo and ligand-containing crystal structures. However,
using single molecule optical spectroscopy in addition to the
static structural data, the nucleotide binding pocket of DNA
polymerase I was shown to exhibit dynamic open-closed equi-
librium in the binary complex with DNA that is shifted toward
the closed conformation upon dNTPbinding (6). In such a case,
the ligandmay bind to a pocket that appears relatively closed on
a millisecond-second time scale.
Homotrimeric dUTPases have three equivalent active sites in
the clefts constituted by two neighboring subunits (Fig. 1) (7, 8).
The C-terminal arm of the third subunit folds over the active
site and shields the substrate from the solvent (Fig. 1A). This
segment of the polypeptide is only visible in protein crystals
that contain substrate analogues. In the apo state, the C-termi-
nal arm is undefined in the crystal structures of dUTPases from
widely different species (9–11). This observation has been
interpreted as an open-closed transition of the C-terminal arm
and the active site. The steady-state conformational states of
theC-terminal armwere probed by a fluorescent sensor (Trp158
in human dUTPase). The measured solvent accessibility of this
sensor in various nucleotide-bound states suggested that the
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arm resides in a relatively closed conformation during the larg-
est fraction of the reaction cycle time (12). A presumed open-
closed conformational transition upon ligand binding could
not be observed. Because of the seeming contradictory evi-
dence between the crystallographic and fluorescence spectros-
copy data, we could not establish a comprehensive model
of substrate binding or product release. To fill this gap, we
implemented the random acceleration molecular dynamics
(RAMD)4 method for its ability to gain high resolution infor-
mation on the enzyme-nucleotide interaction. Under physio-
logical conditions, ligand binding and dissociation usually takes
place on a microsecond-millisecond time scale and requires
several microsecond long molecular dynamics simulation for
accurate modeling (13–16). Therefore, in case of buried active
sites, guided or biased molecular dynamics simulations such as
steered molecular dynamics (17, 18), RAMD (19), and metady-
namics (20, 21) are preferably used to accelerate the process of
ligand binding or dissociation. The RAMDmethod (19) applies
an artificial random oriented force that acts on the ligand and
accelerates the dissociation process, offering a reasonable
time scale for computational simulations. Because of the
reduced simulation time scale and the randomly oriented
force, a larger sample size of ligand dissociation pathways are
explored at atomic resolution. Considering that ligand bind-
ing is a reversible process, this method can be used to explore
substrate dissociation and binding pathways as well (19).
The RAMDmethod has been successfully employed to study
ligand dissociation paths in cytochrome P450 (19), rhodop-
sin (22), haloalkane dehalogenase (23), histone deacetylase
(24), heme oxygenase (25), thyroid hormone receptor (26),
P-glycoprotein (27), and B-RAF kinase (28), among many
others.
High resolution crystal structures (10, 29–35), a detailed
kinetic mechanism (12, 36, 37) and additional regulatory func-
tions (38–40) have already been revealed for dUTPases in a
wide variety of species. Previously, we have investigated the
detailedmechanism of substrate binding, hydrolysis, and prod-
uct release in dUTPase using a combination of structural and
transient kinetics methods (12, 41). These results obtained
from crystal structures and from spectroscopic measurements
on themillisecond time scalemovements did not allow insights
into the possible substrate binding pathways to the hidden
active site of dUTPase. This process may have pharmacological
significance because we have recently shown that the dUTPase
enzyme may be a selective drug target in mycobacteria (42).
This enzyme plays a crucial role in DNA integrity by catalyzing
the hydrolysis of dUTP into dUMP and pyrophosphate, pro-
ducing the precursor for dTTP biosynthesis. At the same time,
the dUTPase reaction is also responsible for balancing a low
intracellular dUTP:dTTP ratio required in most organisms to
avoid DNA uracilation that may have serious consequences
(8, 43).
In this study, we determine the putative ligand shuttling
pathway of dUTP between the solvent and the active site of
theMycobacterium tuberculosis dUTPase using RAMD sim-
ulations in combination with experimental methods includ-
ing X-ray crystallography, fast kinetics, ligand binding, and
solvent accessibility experiments. The results suggested that
active site residues are predominately in the closed confor-
mation over the entire reaction cycle and during the nucle-
otide binding process. We observe a small stretch of amino
acids that slides transiently away with small amplitude
movements to partially uncover the active site. In addition,
4 The abbreviations used are: RAMD, random acceleration molecular dynamics;
PDB, Protein Data Bank; RMSD, root mean square deviation; dUPNPP, 2-de-
oxyuridine 5-,-imido-triphosphate; NATA,N-acetyl-L-tryptophanamide.
FIGURE 1. Three-dimensional structure and conserved motifs of the M. tuberculosis dUTPase. A, three-dimensional structure of the M. tuberculosis
dUTPase enzyme complexed with dUPNPP (PDB code 2PY4 (33)). The subunits are shown as white, cyan, and blue ribbons, whereas the fifth conserved motif
located on the C-terminal arm is highlighted as thick yellow ribbon in all subunits. B, three-dimensional structure of the active site of M. tuberculosis dUTPase
enzyme complexed with dUPNPP (PDB code 2PY4 (33)). The protein backbone is shown as white ribbon, and the conserved motifs are highlighted with stick
representationof different colors (violet,green,orange,blue, and yellow for first, second, third, fourth, and fifth conservedmotif, respectively). dUTP is visualized
by atomic colored stick representation. Mg2 ion, the water molecules of the Mg2 ion coordination sphere, and the catalytic water molecule are shown as
green and red spheres, respectively. C, amino acid sequence of theM. tuberculosis dUTPase. The conserved motifs are color-coded according to B.
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this is the first study that demonstrates direct experimental
validation of the powerful RAMD method.
Results
RAMD Simulations Reveal the High Spatiotemporal Resolu-
tion Movements of the Active Site upon Substrate Unbinding—
Of 72 individual RAMD simulations performed, 55 led to pro-
ductive dissociation of the ligand from the active site. In the
remaining 17 runs, the ligand did not exit the active site during
the entire 300-ps length of the simulations. A representative of
unproductive simulations can be seen in Fig. 2.
Based on the order of dissociation of the substrate from the
various interaction points within the protein listed below, the
55 productive RAMD runs could be classified into five major
unbinding pathways A–E (Fig. 3). The difference between these
paths can be best appreciated visually by watching supplemen-
tal Movies S1–S5. To understand the classification criteria in
the text format analysis in Table 1, it is crucial to describe the
interactions of the substrate within the active site. The first
conservedmotif (violet in Fig. 1,B andC) coordinates theMg2
of the physiological substrate-Mg2 complex through water
molecules. The second and fourth motifs (green and blue,
respectively in Fig. 1, B and C) coordinate the phosphate chain
of the substrate, whereas the thirdmotif (orange in Fig. 1, B and
C) maintains interactions with the uracil and deoxyribose moi-
eties of the nucleotide (35). The fifth motif (yellow in Fig. 1, B
and C) located on the C terminus coordinates the -phosphate
and the uracil ring of the substrate and is responsible for
diphosphate/triphosphate ligand discrimination mainly by
promoting hydrolysis of the triphosphate nucleotide (41). In
agreement with this, it has been shown in a wide variety of
dUTPases that the enzymatic activity of C-terminally truncated
mutants is drastically lower (practically 0) than that of the WT
(11, 34, 37, 41, 44, 45).
The structural element in the focus of the present study is the
fifth motif as it shields the nucleotide binding cavity and
restricts nucleotide shuttling. Fig. 4 highlights the position of
this motif relative to the observed exit routes and also shows its
overall conformational change between the initial and final
time points of the RAMD runs. In pathway A, the N-terminal
part of the C-terminal arm transiently moves away from the
enzyme core as the substrate leaves the active site, whereas the
FIGURE 2. A representative of the 17 unproductive RAMD runs. The
enzyme can be seenwith gray surface representation. For clarity, the C-termi-
nal arm is omitted from this picture. dUTP is visualizedas atomic coloring stick
model, and Mg2 is an orange sphere. The path of the center of mass of the
dUTP-Mg2 complex is visualized as a blue,white, and red line.
FIGURE 3. Exit routes of five representative simulations from the five major ligand unbinding pathways. A, the enzyme is shown with light blue ribbon
model, and theC-terminal arm is highlighted as flat yellow ribbon. The curves, representing the fivemajor pathways, are the spheremodels of the center ofmass
of the dUTP-Mg2 complex during the course of simulations. B, the same structures upon rotating the protein by 90°.
TABLE 1
Analysis of the five ligand binding pathways
In the RMSD calculation, 305 atoms (residues 130–154) were superposed.
Pathway name A B C D E
Number of runs 6 6 18 19 6
Substrate dissociation from indicated protein
segments in the order of interaction break-up
(M stands for conserved motif)
M4 M1 M3 M3 M3
M2 M4 M1 M2 M2
M1 M3 M2 M1 M4
M3 M2 M4 M4 Phe55
M5 Leu44 M5 M5 Val119–Glu123
Lys91 M1
M5 M5
Maintenance of octahedral coordination between
Mg2 and the phosphate oxygens of dUTP
No Yes No Yes Yes
RMSD of the C-terminal arm (Å) 5.6 1.4 3.4 0.5 6.7 2.2 4.6 0.8 6.3 1.3
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rest of the C-terminal arm keeps its position (Fig. 4A and sup-
plemental Movie S1). In pathway C, partial unfolding of the
C-terminal arm can be observed, whereas all intermolecular
contacts are broken between the C-terminal arm and the pro-
tein core (Fig. 4C and supplemental Movie S3). In contrast, the
C-terminal arm moves on the surface of the protein without
losing its interactions with the rest of the protein in pathways B,
D, and E (Fig. 4, B, D, and E, and supplemental Movies S2, S4,
and S5). In three of the runs (shown in green, orange, and gray in
Fig. 4E), the route of ligand exit changes its direction after its
initial progress, which is due to a steric clash with the first con-
servedmotif forcing the ligand to exit at different directions.
Another subtle difference that was observed during the anal-
ysis of the RAMD runs was that in pathways A andC, but not in
pathways B, D, or E, the coordination geometry betweenMg2
and the phosphate chain of dUTP (Fig. 5) becomes distorted as
the ligand exits the active site (Table 1). This distortion coin-
cides with a larger conformational change of the C-terminal
armas also reflected by the rootmean square deviation (RMSD)
for the C-terminal arm between the initial and final conforma-
tions (Table 1).
Importantly, the C-terminal arm remains close to the
enzyme core in each RAMD simulation as opposed to opening
up completely and exposing the active site to the solvent (sup-
plemental Movies S1–S5). A quantitative analysis of the dis-
placement of amino acids within the C-terminal arm can be
viewed in Fig. 6. The small RMSD values characteristic to
amino acids 130–135 and 150–155 indicate that the proximal
and distal regions of the arm stay in contact with the enzyme
core. The fifth conserved motif is situated in between these
sequences and takes active part in the ligand exit process as
reported by the elevated RMSD values. His145 acts as the aro-
matic lid over the active site present in all dUTPases by engag-
ing in a - stacking interaction with uracil (Fig. 1B) (35, 46).
This interaction was earlier exploited to study the enzymatic
cycle as it reports on ligand binding and product unbinding
using various spectroscopicmethods (12). The high RMSD val-
ues of His145 explain the observed spectroscopic changes and
reinforce the importance of- stacking interactions in direct-
ing ligand exit (47). Arg140, responsible for -phosphate coor-
dination, also displays relatively high RMSD values in pathways
A and E. This phenomenon will be discussed in the subsequent
sections.
These RAMD results provide the first body of evidence that
reconciles all the previous ensemble spectroscopic measure-
ments and crystallographic data concerning the movements
and role of the C-terminal arm during substrate binding. Upon
substrate binding or product release, the nucleotide moves
through small and transient spaces available as a stretch of the
C-terminal polypeptide chain moves away from the shielding
position. Such amechanism involves relatively small conforma-
tional changes (12) of a yet dynamic C-terminal arm (37, 48)
and a relatively closed active site even without bound substrate
(12).
New Substrate-dependent Interaction Point Detected in the
RAMD Runs—During detailed analysis of the pathways, some
less conserved residues in the neighborhood of the conserved
motifs appeared to take active part in the substrate unbinding
FIGURE 4. Initial structures and exit routes of the dUTP-Mg2 complex of
all simulations (panels A1–E1) and end point protein structures of repre-
sentative runs (panels A2–E2) from the five major pathways (A–E). The
enzyme is shown as light blue ribbon model, and the C-terminal arm is high-
lighted as flat ribbon. The curves representing the runs are the sphere models
of the center of the dUTP-Mg2 complex during the course of simulations.
Arrows indicate the notable conformational changes between the start and
end point structures.
FIGURE 5. Schematic representation of the dUTP-Mg2 complex. The
coordination sphere of theMg2 ion is constituted from thephosphate chain
of dUTP and three water molecules.
FIGURE 6. Maximal RMSD values of single amino acids in the C-terminal
arm during the five representative RAMD runs.
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process. Particularly, a yet undescribed stacking interaction
between the imidazole ring of His21 (N-terminal of the first
conserved motif) and the guanidino group of Arg140 (fifth con-
served motif) residues displayed characteristic changes. This
interaction in pathways A and E seems to break up as the ligand
exits the active site (Fig. 7 and supplementalMovies S1 and S5),
also explaining the large displacement of Arg140 indicated in
Fig. 6. In the other three pathways, this interaction persists
during the entire simulation. We found this phenomenon
interesting because it directly involves the opening of the active
site and the anchoring of the C-terminal arm (Arg140) to the
enzyme core (His21). We carried out the further detailed bio-
chemical and structural biology experiments to validate this in
silico observation and to learnmore about the substrate binding
process.
Implementation of a Reporter to Study the His21-Arg140
Interaction—To continuously monitor the interaction between
His21 and Arg140 during the reaction cycle, we introduced a
single Trp fluorescent sensor into position 21. We already had
experience with His to Trp changes in this protein that left the
protein fold and activity unaffected and provided useful signals
(33, 42, 49). Position 21 is conserved in the bacterial phylum
Actinobacteria. Tyr may replace His in some sequences
(Atopobium,Olsonella, and Actinoplanes), which also suggests
that the aromatic nature of the amino acid in this position is
important. The H21W point mutant M. tuberculosis dUTPase
was thus generated to study the dynamic behavior of the inter-
action between the protein core and the C-terminal arm of the
protein.
Crystal Structure of the H21W Mutant—The crystal struc-
ture of the H21W mutant has been solved to 1.5 Å resolution
and deposited to the PDB database under code 4GCY (for crys-
tallographic data see Table 2). The global structure of the
mutant enzyme is highly similar to the WT (PDB code 2PY4
FIGURE 7. Snapshots from pathways A and E showing the His21–Arg140 interaction. The initial enzyme structure is shown as light blue ribbon model,
whereas the actual structure during the course of the simulation is shownas ablue and yellow ribbonmodel for pathwaysA (panels A1–A3) and E (panels B1–B3),
respectively. The C-terminal arm is highlighted as thick ribbon in all cases. The dUTP-Mg2 complex and the His21 and Arg140 residues are visualized as stick
modelswith atomic coloring, and the hydrogen atoms are omitted for clarity.
TABLE 2
Data collection and refinement statistics of PDB code 4GCY
Space group P 63
Unit cell
a, b, c (Å) 54.94, 54.94, 83.86
, ,  (°) 90, 90, 120
Resolution (Å) 27.95–1.50 (1.58–1.50)a
Total no. of reflections 173,193
No. of unique reflections 23,022
Redundancy 7.5 (4.8)
Completeness (%) 100 (100)
I/(I) 11.8 (2.1)
Rmeas (%)b 0.085 (0.578)
Refinement
No. of protein atoms 1216
Ligand atoms/water/Mg2 ions 28/156/1
Rcryst/Rfree (%)c,d 12.35/15.62
Overall B-factors (Å2)e 25.862/21.482/27.401/22.047
Deviations from ideal stereochemistry
RMSD bonds (Å) 0.015
RMSD angles (°) 1.555
Ramachandran plot analysisf
Most favored (%) 99.30
Additionally allowed (%) 0.70
Disallowed (%) 0.00
a The values in parentheses are for the highest resolution shell.
b Rmeas 	n/(n
 1)1/2 (Ii
I )/(I), where the sum is calculated over
all observations of a measured reflection (Ii), andI is the mean intensity of
all the measured observations (Ii).
c Rcryst  (Fobs
 Fcalc)/ (Fobs), where Fobs is the observed structure factor
amplitude, and Fcalc is that calculated from the model.
d Rfree is equivalent to Rcryst but where 5% of the measured reflections have been
excluded from refinement in thin shells and set aside for cross-validation
purposes.
e Average B values for all atoms/ ligand atoms/water/Mg2 ions.
f Ramachandran plot analysis was fromMolProbity.
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(33)), which is clearly demonstrated by the 0.2 Å RMSD of the
protein backbone atoms (Fig. 8A). It should be mentioned that
parts of the flexible termini of the structure are affected by
slight model bias and are flagged as real space R value Z score
outliers. This, however, does not affect the accurate interpreta-
tion of the protein core and the discussed residues of interest.
Thus, the active site can be considered as equivalent to that of
the WT. The RMSD of the non-hydrolyzable substrate ana-
logue dUPNPP-Mg2 complexes in the reference and new
structure is 0.1 Å. The mutant Trp side chain is in the same
position as the His side chain in the WT (Fig. 8B), despite the
fact that the indole ring of the Trp residue is larger and more
hydrophobic than the imidazole ring of theHis. The indole ring
establishes similar interactions with the backbone atoms of
Ser139 and Arg140 and with the side chain of Arg140 (Fig. 8C) to
those of the imidazole ring (Fig. 8D). The hydrogen bond with
the side chain of Ser139 vanished upon the substitution. Arg140
is the first residue of the fifth conserved motif. It has a crucial
role in the coordination of the -phosphate of the substrate by
a bifurcated hydrogen bond (10) and hence in the enzymatic
catalysis (41, 50). These structural similarities suggest a WT
behavior for the H21W mutant similar to a previously
describedH145Wmutant, where themutated aromatic residue
stacks against the uracil ring of the substrate establishing a-
stacking interaction (35).
Enzymatic Mechanism Probed by Transient Kinetics—The
kcat of the H21Wmutant was measured to be 2.9 s
1 (Table 3)
which is comparable with that of the WT (3.1 s
1 according to
Pecsi et al. (35)). Next, we assayed whether the fluorescence of
the Trp21 residue reports any events of the reaction cycle. Sur-
prisingly, the H21Wmutant displays similar fluorescent signal
change during the enzymatic cycle as previously reported for
the H145W active site Trp mutant (Fig. 9A) (35, 49). In the
H21Wmutant, however, the Trp residue is outside of the active
site, presumably far from the substrate during the chemical
reaction. It is only connected to the active site through the
interaction with Arg140 pointed out in our RAMD runs. This
suggests that the movements of the C-terminal arm during the
reaction are efficiently transmitted to the Trp21 residue. As a
result, the fluorescence intensity of the Trp21 residue decreases
upon substrate binding and remains quenched in the steady-
state hydrolysis phase to recover upon products dissociation
(Fig. 9A).
Using the large fluorescent signal, we recorded time courses
in substoichiometric dUTP concentrations in the stopped flow
apparatus to obtain the true single turnover rate constant (ksto)
of the dUTPase reaction (Fig. 9A). The exponential fit to the
fluorescence recovery phase yielded ksto 3.1 s
1. The obser-
vation that kcat equals ksto with a fluorescent reaction profile
similar to that of the H145W dUTPase implies the same enzy-
matic mechanism in which dUTP hydrolysis is rate-limiting
(12).
The kinetics of dUTP binding was also measured using
stopped flow (Fig. 9B). For comparison, the yet undescribed
substrate binding kinetics ofH145Wwasmeasured as well (Fig.
9C) (our previous kinetic investigation (12) was carried out
using the human enzyme). The observed ligand binding rate
constants are plotted against the ligand concentration and fit-
ted with linear functions to obtain the microscopic association
and dissociation rate constants (kon and koff, respectively; Fig. 9,
D and E, and Table 3). Compared with the human enzyme, the
M. tuberculosis H145W enzyme displays similarly high koff
value and somewhat lower kon value. Rate constants of the
H21W mutant are in the same range as those for the H145W;
however, there is a 3.5-fold decrease in the kon value and a 50%
increase in the koff value. The apparent dissociation constants
of the enzyme-dUTP complexes could not be determined from
the amplitudes of the fluorescence change caused by saturating
conditions. In view of the structural similarity between the two
FIGURE 8. Crystal structure of the H21Wmutant. A, superimposition of the
WT M. tuberculosis dUTPase (PDB code 2PY4 (33), orange) and the H21W
mutant (PDB code 4GCY, violet). The proteins are visualized as colored ribbon
model, and dUPNPP can be seen as atomic colored sticks. The global struc-
tures of the two proteins are highly similar, which is supported by the 0.2 Å
RMSD of the protein backbone atoms. B, enlarged view of A, where the side
chains of the mutated residues are shown as stick models. The indole ring of
the Trp residue and the imidazole ring of the His residue are in the same
position. C and D, possible interacting points of the Trp21 residue (C) or the
His21 residue (D) are Ser139 and Arg140 from the crystal structure of the H21W
mutant (C) or the WT M. tuberculosis dUTPase (D). Arg140 is coordinating the
-phosphate oxygen of the substrate. The protein backbone is shown as vio-
let (C) or orange (D) ribbonmodel, and the residues and the non-hydrolyzable
substrate analogue dUPNPP can be seen as atomic colored sticks.
TABLE 3
Kinetic and thermodynamic parametersmeasured for theH145Wand
H12WM. tuberculosis dUTPase mutants
kcat, catalytic rate constant obtained from steady-state measurements; k1 on, second
order dUTP binding rate constant obtained from stopped flowmeasurements; k1 off,
dUTP dissociation rate constant obtained from stopped flow measurements; k2 obs,
observed isomerization rate constant for dUTP binding; Kd,dUPNPP, dissociation
constant for the enzyme-dUPNPP complex obtained from equilibrium fluorescence
titration; Kd,dUDP, dissociation constant for the enzyme-dUDP complex obtained
from equilibrium circular dichroism titration.
H145W H21W
kcat (s
1) 3.1 0.06 (35) 2.9 0.3
k1 on (s
1 M
1) 29.2 1.7 8.0 0.7
k1 off (s
1) 104 20 165 13
k2 obs (s
1) 13.2 2.4 36.2 12.4
Kd,dUPNPP (M) 0.32 0.1 2.9 0.6
Kd,dUDP (M) 22.5 9.4 1.9 1.0
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enzymes (Fig. 8), it was not expected that the ligand binding
process would be much slower when a Trp residue is present
instead of a His in position 21. This change, however, further
proves that this residue is involved in the ligand binding
pathway.
Ligand Binding—To reveal more mechanistic details of the
involvement of residue 21 in the ligand binding/dissociation
pathways, we carried out comparative fluorescence and circular
dichroism studies. The fluorescent spectra of the apo H21W
mutant enzyme and its complexes with dUMP, dUDP, and the
dUTP-mimicking, practically non-hydrolyzable dUPNPP were
recorded (Fig. 10A). The relative fluorescence quench induced
by these ligands differs considerably from that observed previ-
ously in the H145Wmutant (Fig. 10B). Only dUPNPP induced
a significant fluorescence intensity decrease, whereas the dUDP
and dUMP complexes of the H21Wmutant remained fluores-
cently silent. In contrast, all ligand-enzyme complexes of
H145W show a decrease in fluorescence intensity (49) accord-
ing to the extent of C-terminal arm rigidity, which stabilizes the
stacking interaction between the indole ring of Trp and uracil
(12). The Trp incorporated in the H21W mutant thus only
reports the binding of the triphosphate nucleotides. This phe-
nomenon is consistent with the RAMD results, suggesting that
the Trp21 residue is in interaction with Arg140 responsible for
coordinating the -phosphate of the ligand exclusively (Fig.
8C). The dissociation constant of the enzyme-dUPNPP com-
plex was determined using fluorescence intensity titrations and
was found to be 1 order of magnitude larger than that of the
H145W-dUPNPP complex (Fig. 10C).
Binding of dUDP could not be measured using fluorescent
titration in a lack of a detectable signal (Fig. 10A). However, to
ensure that dUDP indeed binds to the H21W mutant, circular
dichroism titration measurements were performed. Determi-
nation of the Kd of the enzyme-dUDP complex using this
method is only possible with relatively high error because the
concentrations applied in themeasurements are necessarily far
above the Kd. Nevertheless, it is clear from the data that the
H21W mutant binds dUDP significantly tighter than the
H145W (p 0.046) (Fig. 10D).
The results of the nucleoside mono-, di-, and triphosphate
binding experiments togetherwith theRAMDdata suggest that
Trp21 senses the nucleotide-bound state of the active site
through its interaction with Arg140. Arg140 probably remains in
the apo state conformation when only monophosphate or
diphosphate nucleotides bind to the active site (Fig. 10A).
Because the C-terminal arm (including Arg140) is usually only
visible in crystal structures that contain the triphosphate
ligand, the apo state conformation of Arg140 has never been
reported before. However, the dUDP-complexed structure of
theM. tuberculosis dUTPase is available for comparison for the
position and mobility of Arg140 in two different nucleotide-
bound states (Fig. 11). By comparing the relative B-factors of
Arg140 within the same structure in Fig. 11 (A and B), it is clear
that with a lack of the -phosphate, the mobility of the Arg
residue is much higher. This phenomenon suggests that only a
relatively static Arg140 is able to change the fluorescence prop-
erties of Trp21, probably through cation- interaction, and thus
yields a specific sensor for nucleoside triphosphate binding. It is
interesting that modification of the electrostatic properties of
the aromatic interacting partner (i.e. His to Trp change) per-
turbed the nucleotide affinities to the enzyme (Table 3). A pos-
sible explanation to this phenomenon may be that the Arg140–
FIGURE9.Fast kinetics of theH21WandH145Wmutants. The latterwasdescribedearlier to displayWTbehavior (35).A, the fluorescence time courses of the
H21Wmutanthydrolyzing sub- and superstoichiometric amounts of substrate showsimilar progression to those reported for theH145Wmutant. 3Menzyme
wasmixedwith various concentrations of dUTP (post-mix concentrations). Triple exponential functionwas fitted to the single turnover curve obtained for the
lowest, substoichiometric dUTP concentrationwhich yielded 3.1 s
1 for the third phase (k1,obs 69 s

1, k2,obs 3.6 s

1). In earlierworks, this rate constantwas
identifiedas the single turnover rate constant (kSTO) (12).BandC, dUTPbinding to theH21W(B) or to theH145W(C)mutant. 1Menzymewasmixedwithbuffer
or with various concentrations of dUTP in pseudo first order conditions. Double exponential function was fitted to the data. D, concentration dependence of
theobservedcatalytic rate constants of the fast phaseofdUTPbinding (kobs,1). E, concentrationdependenceof theobservedcatalytic rate constants of the slow
phase of dUTP binding (kobs,2). This phase seems to be independent of the substrate concentration in agreement with previous data.
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Trp21 interaction is more stable than the Arg140–His21
interaction in the WT. This in turn results in less frequent dis-
location of the C-terminal arm (Fig. 7) and finally in the slower
kinetics observed for dUTP binding (Table 3).
Solvent Accessibility—The solvent accessibility of the incor-
porated Trp21 residue was measured by acrylamide quenching
to obtain further dynamic information about the vicinity of the
studied interaction. The acrylamide quenching of N-acetyl-L-
tryptophanamide (NATA) wasmeasured as reference and con-
trol for a rotationally free andmaximally solvent-accessible Trp
residue. The quenching constants (KSV) for the apo and
the dUPNPP-bound enzymes were similar and significantly
reduced compared with NATA (Fig. 12). The solvent accessi-
bility of the active site Trp in the apo state and in the dUPNPP-
bound complex are also shown for comparison (12). The com-
parative data indicate that the Trp21 residue is buried similarly
to the active site Trp. This suggests that part of the C-terminal
arm shielding Trp21 from the solvent is associated to the pro-
tein core in equilibriumeven in the apo enzyme. Consistently in
all of the RAMDruns, we also observed that theC-terminal arm
remains associated with the enzyme core following dUTP
dissociation.
Discussion
This study combined computational, biochemical, and bio-
physicalmethods to gain insights into the nucleotide binding of
a nucleotide-hydrolyzing enzyme at exceptionally high time
and structural resolution. The RAMD method provided the
high time and structural resolution, whereas the numerous
experimental data served to validate the results of the compu-
tational simulation. In terms of mechanistic detail, the RAMD
runs can be regarded as fast transient kinetics experiments on a
FIGURE 10. Fluorescence and circular dichroismstudies of ligandbinding to theH145WandH21Wmutants.A, fluorescence spectra of theH21Wmutant
enzyme with and without nucleoside mono-, di-, and triphosphate ligands. B, fluorescence intensities of the H145W (49) and H21W mutant enzymes with
saturating ligand concentrations. C, fluorescence titration of H145W and H21W with the dUPNPP substrate analogue; quadratic fit to the data yielded
dissociation constants (Kd,dUPNPP) shown in Table 3.D, circular dichroism titration of H145WandH21Wwith dUDP; quadratic fit to the data yielded dissociation
constants (Kd,dUDP) shown in Table 3.
FIGURE 11. Thermal mobility of the Arg140 residue in various ligand
boundcomplexes.Theenzyme is shownas thick transparent ribbon,whereas
the ligand and Arg140 are visualized as sticks. Coloring represents the relative
crystallographic B factor for each atom (blue, less mobility; red, more mobil-
ity).A, the structure ofM. tuberculosisdUTPase complexedwith dUPNPP (PDB
code 1SIX (10)). B, the structure of M. tuberculosis dUTPase complexed with
dUDP (PDB code 1SLH (10)). Note that Arg140 is in different conformation and
that Arg140 has muchmoremobility compared with the dUPNPP-complexed
structure.
FIGURE 12. Solvent accessibility of Trp21 with and without ligand bound
to the protein. Acrylamide titration curves are shown. The modified Stern-
Volmer equation was fitted to the data yielding quenching constants 18.8,
6.4, 7.1, 6.7, and 5.3 M
1 for NATA, apo H21W, dUPNPP-bound H21W, apo
active site Trp, and dUPNPP-bound active site Trp, respectively.
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single molecule level. It appears that the assembly of the phe-
nomena observed in single RAMD runs agrees well with the
ensemble solution kinetics results presented earlier. The RAMD
models reveal how the substrate can leave/enter the active site
without completely opening the C-terminal arm. A previously
hypothesized mechanism like a “hinge door” in which the
C-terminal arm completely opens up at the hinge of a con-
served Pro (51) was not observed in the RAMD simulations.
Instead, we observed the nucleotide shuttling between the
active site and the solvent through small openings of the C-ter-
minal arm. The arm, fixed at both ends to the enzyme core via
secondary interactions, moves only by sliding away close to the
enzyme surface or by opening partially and locally. These
movements involving 10–15 residues are small compared to
the conformational changes observed for other nucleotide
binding enzymes (4, 5, 52). In DNA helicases and polymerases,
substrate binding involves displacement of whole domains
(1–3, 6). It should be mentioned that the RAMD method may
not be capable ofmodeling large loopmotions because relevant
reports are missing. However, our computational simulations
and spectroscopic results together unequivocally support
the finding that small loop movements allow the shuttling of
the nucleotides between the binding pocket and the solvent
in dUTPase, whereas larger scale movements may not be
excluded.
There may be an apparent contradiction between the C-ter-
minal arm not being visible in the crystal structures and the
RAMD simulations showing only small amplitude movements
of the C-terminal arm. These phenomena, however, are com-
plementary. The electron density maps represent the average
conformation of all atoms in a protein crystal. The inability to
localize an entity may be due to movements on a small ampli-
tude scale just exceeding the atomic distance. Molecular
dynamics simulations, on the other hand, investigate single
molecules rather than a population average and commonly
reveal small amplitude movements. The example of dUTPase
demonstrates that the comparison of crystal structures in var-
ious nucleotide-bound states alone is not fully informative of
the nucleotide binding mechanism.
This study yielded novel insights regarding the dynamics and
other properties of the interaction between dUTP andMg2 as
well. The RAMD method offered a unique opportunity to
observe that this interaction is maintained during the whole
ligand binding/unbinding process, although the octahedral
coordination between Mg2 and dUTP became distorted in
some of the pathways.
As proof of principle, we chose the His21 residue de novo
predicted by the RAMD simulations to be involved in substrate
dissociation to validate our data. It turned out that the replace-
ment of this residue with a Trp yielded a sensitive fluorescence
reporter specific to triphosphate nucleotide binding. As such,
Trp21 reported the hydrolysis reaction similarly to the active
site nucleotide sensor, Trp145. Using the combination of struc-
tural and optical spectroscopic methods, we proposed a possi-
ble molecular mechanism for nucleotide sensing by Trp21 rela-
tively far from the active site. This phenomenon also shines
light onto the possibility to exploit this specific interaction in
target-based drug design against actinobacterial pathogens.
Experimental Procedures
System Preparation for Molecular Dynamics Simulation—
The initial structure for the simulations was the crystal struc-
ture of theM. tuberculosis dUTPase complexed with dUPNPP
(PDB code 2PY4 (33)). The original dUPNPP ligand in the crys-
tal structure was manually modified to dUTP. The protonation
states of the titratable groups were determined by means of the
ProPka algorithm (53, 54) at pH 7.4, and the optimization of
hydrogen bonding interactions was performed using the
PDB2PQR program package (55). The structure obtained was
solvated using the TIP3P water model (56), and a minimum
distance of 14 Å was used between any atom of the protein and
the wall of the periodic box. The number of Na cations and
Cl
 anions was 49 and 34, respectively, to neutralize the system
and mimic the physiological ionic strength (0.15 M NaCl). For
description of the protein and dUTP, the CHARMM27 param-
eters (57) including the CMAP correction term for proteins
(58) were applied, whereas the ions were described by the
parameters of Beglov and Roux (59).
Molecular Dynamics Simulations—Molecular dynamics
simulations were performed with the NAMD2.7 software (60)
applying the following protocol: (i) 1600 steps minimization
with restrained protein atoms using a 10 kcal mol
1 Å
2 force
constant; (ii) 3200 steps minimization; (iii) 32-ps NVT dynam-
ics, where number of atoms (N), volume (V), and temperature
(T) are fixed (T  310 K, Langevin dynamics (61)) with
restrained protein atoms using a 10 kcal mol
1 Å
2 force con-
stant; and (iv) NPT dynamics, where number of atoms (N),
pressure (P), and temperature (T) are fixed (p  1 atm, T 
310 K) with the Noose´-Hoover Langevin piston method (61,
62). The time step was set to 1 fs, a cutoff value of 10 Å was
applied (using a smoothing function from 8 Å), and the long
range electrostatic interactions were calculated with the Parti-
cle Mesh Ewald (PME) method (63). Two independent, 2-ns-
long simulationswith different initial velocitieswere conducted
to relax the system, and the structures of the last frames were
used in the subsequent RAMD simulations. During the 300-ps-
long RAMD simulations, the acceleration was set to 0.066 kcal
mol
1 Å
1 (atomic mass unit)
1, and the successful exit event
was accepted if the distance between the center of mass of pro-
tein and that of dUTP was larger than 50 Å. Every 80 fs, new
orientation was generated if the distance traveled by the ligand
was less than 0.1 Å, and the trajectory was saved every 80 fs. No
restraints were applied when conducting the RAMD simula-
tions. From both starting structures and every binding cavity,
12 RAMD simulations were started resulting in 72 calculations.
Once the ligand escapes into the solvent, the dissociation path-
way becomes smooth because of the constant force acting on
the substrate. This linearity of the ligand trajectories within the
bulk solvent is irrelevant for the ligand finding the possible
paths out of the active site.
Analysis of the Trajectories—Analysis of the trajectories was
performed with the Visual Molecular Dynamics (64) package,
which was used to generate Figs. 1–4, 7, 8, and 11 and supple-
mental Movies S1–S5.
Reagents—Molecular biology products were from New Eng-
land Biolabs and Fermentas, electrophoresis and chromatogra-
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phy reagents were from Bio-Rad and Qiagen. Phenol red was
fromMerck, dUDPanddUPNPPwas from JenaBioscience, and
dUTP and other chemicals were from Sigma-Aldrich.
Mutagenesis—To generate theM. tuberculosisH21Wmu-
tant dUTPase, site-directed mutagenesis was performed by
Stratagene’s QuikChange method and was verified by
sequencing. The mutagenic forward and reverse primers
were 5-GCCCAGCCGCGCTTGGGACGGCGACGCCG-
GCG-3 and 5-CGCCGGCGTCGCCGTCCCAAGCGCGG-
CTGGGC-3.
Cloning, Protein Expression, and Purification—were per-
formed as described previously in Ref. 33. Recombinant dUTPase
with an N-terminal His6 tag was transformed into Escherichia
coli strain Rosetta(DE3)pLysS, which was used for protein
expression. The final supernatant after cell extraction was
loaded on a nickel-nitrilotriacetic acid column (Novagen) and
purified according to the Novagen protocol. Because wild type
lacks a useful tryptophan to monitor ligand binding, we have
used the H145W mutant for kinetic studies. This tryptophan
substitution in the active site has been previously shown to not
affect catalytic activity (33). Protein concentration was mea-
sured using the Bradfordmethod (Bio-Rad protein assay) and is
given in subunits. Protein was dialyzed against buffer pH 7.5,
containing 20 mM HEPES, 100 mM NaCl, 2 mM MgCl2, and 1
mM DTT, and measurements were carried out in this buffer if
not stated otherwise.
Crystallization—The H21W mutant was crystallized as
described for theWT enzyme using the hanging drop diffusion
method (33). 250 M dUTPase and 1.25 mM dUPNPP were
mixed with the reservoir solution containing 50 mM Tris-HCl,
pH7.5, 10mMMgCl2, 1.20–1.75M ammonium sulfate, and 10%
glycerol in a 1:1 ratio.
Data Collection and Structure Determination—High resolu-
tion complete crystallographic data set from a single flash fro-
zen crystal was collected at Eo¨tvo¨s University using RIGAKU
RU-H2R rotating anode home source at  1.5418 Å on 100 K
temperature. Reflection data were recorded on RIGAKU
R-AXIS IV image plate detector.
Data reduction was performed using iMosflm and Scala pro-
grams and the CCP4 program suite (65). The structure of the
H21Wmutant in complex with dUPNPP andMg2 was deter-
mined by molecular replacement using MolRep, where the
model was the WT dUTPase structure (PDB code 2PY4 (33)).
Rmerge  (Ii 
 I )/(I), where the sum is calculated
over all observations of a measured reflection (Ii), and I is
the mean intensity of all the measured observations (Ii).
Manual model building was carried out running the Win-
Coot program (66). Refmac5 software from CCP4 program
package (65) was used for high resolution refinement. Rfree val-
ues were computed from cross-validation throughout the
refinement, using 5% random subset of the data set. Ramachan-
dran statistics were as follows: 99.3% favored, 0.7% additionally
allowed, and 0% generously allowed. The coordinates and
structure factor data have been deposited in the Protein Data
Bank under PDB code 4GCY.
Steady-state Colorimetric dUTPase Assay—Steady-state col-
orimetric dUTPase assaywas performed as described in Ref. 35.
Phenol red indicator assay was used to detect protons released
in the dUTPase reaction. 0.1 M protein was used in a buffer
containing 1 mM HEPES, pH 7.5, 100 mM KCl, 40 M phenol
red, and 5mMMgCl2. A Specord 200 (Analytic, Jena, Germany)
spectrophotometer and 10-mm-path length cuvettes were used
at 20 °C, and absorbance was recorded at 559 nm. Initial veloc-
ity was determined from the first 10% of the progress curve.
Stopped Flow Experiments—Measurements were done using
an SX-20 (Applied Photophysics) stopped flow apparatus as
described in Refs. 12 and 35. Trp fluorescence was excited at
297 nm, and emission was selected with a 320-nm long pass
filter. Time courses were recorded upon mixing sub- and
superstoichiometric concentrations of dUTP with 1 or 3 M
enzyme at 20 °C (post-mix concentrations). Single turnover
curves could be fittedwith three exponentials (12). The two fast
phases represent ligand binding, whereas the third, fluores-
cence recovery phase represents the hydrolysis-limited product
release event and yields the single turnover rate constant (12).
The fluorescence decrease of the time courses resulted from
mixing excess dUTPover active sites andwas fittedwith double
exponential function. Each time course shown is the mean of
five measurements recorded sequentially in the same experi-
ment. The kobs versusdUTP concentration plots show themean
and standard error of three independent measurements. Time
courses were analyzed using the curve fitting software provided
with the stopped flow apparatus or by Origin 7.5. (OriginLab
Corp., Northampton, MA).
Determination of the Enzyme-Ligand Dissociation Constants—
Determination of the enzyme-ligand dissociation constants
was done by fluorescence intensity titrations and circular dichr-
oism intensity titrations. Fluorescence intensity titrations were
recorded at 20 °C on a Jobin Yvon Spex Fluoromax-3 spectro-
fluorometer with excitation at 295 nm (slit, 1 nm), emission at
347 nm (slit 5 nm) using proteins at 4 M concentration as
described in Ref. 49. CD spectra were recorded at 20 °C on a
JASCO 720 spectropolarimeter using a 10-mm-path length
cuvette. Protein concentrationwas 50M in a buffer containing
20 mM HEPES, pH 7.5, 50 mM NaCl, and 2 mM MgCl2. A spec-
trum between 250 and 290 nmwas recorded at each nucleotide
concentration as described in Ref. 35. Differential curves were
obtained by subtracting the signal of the ligand alone from that
of the corresponding complex. Differential ellipticity at 269 nm
was plotted against the ligand concentration to obtain the bind-
ing curves.
In both types of measurement, protein solution was titrated
with dUPNPP or dUDP using small volumes from a concen-
trated stock solution. The following equation describing 1:1
stoichiometry for the dissociation equilibrium was fitted to the
titration data,
y 	 s 

A	c 
 x 
 K  c 
 x 
 K2  4cx
2c
(Eq. 1)
where x is the nucleotide concentration, y is the fluorescence or
circular dichroism intensity, s y at x 0,A is the amplitude of
the fluorescence or circular dichroism intensity change, c is the
enzyme concentration, and K is the dissociation constant (Kd).
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Acrylamide Quenching—Acrylamide quenching was carried
out by the addition of small volumes of a 5 M acrylamide solu-
tion to the enzyme, enzyme-dUPNPP, or NATA solutions as
described in Ref. 12. Raw data were corrected for the fluores-
cence arising from the acrylamide solution itself. F0/F versus
[Q] curves were analyzed using a modified Stern-Volmer
equation,
F0/F 	 1 
 KSV	Qe
V	Q (Eq. 2)
where F0 is the unquenched, F is the quenched fluorescence,
[Q] is the quencher, KSV is the dynamic (bimolecular) quench-
ing constant, andV is the static (sphere of action) component of
quenching.
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